Bulletin board

Pharmacy Permit Renewals Due by November 1

Pharmacy managers must submit the online Pharmacy Permit Application for Renewal and fees; and meet the requirements of SCPP legislation no later than November 1, 2019. more

[directions] Newsletter Oct 2019

The October edition of [directions], specific to the COMPASS program and medication and patient safety, is now available. Click here to download the most recent edition.

Doctor’s Licence Suspensions

Dr. El-fellani Mohammed’s (Regina) licence has been suspended from October 13, 2019 to January 12, 2020. Effective October 14, 2019, Dr. Alfred Ernst’s (Rosetown) licence is suspended for two months. The complete penalty decisions will be posted on the College of Physicians and Surgeons of Saskatchewan’s website later this week. Please refer to SCPP’s Prescription Validity document regarding new prescriptions or refills in these situations.

Health Canada Advisory - Ranitidine

Health Canada is advising Canadians that it is aware that the impurity N-nitrosodimethylamine (NDMA) has been detected in some ranitidine drugs. NDMA is classified as a probable human carcinogen, which means long-term exposure to levels above what is considered safe could increase the risk of cancer. Health Canada is working to better understand the issue and whether there may be a risk to Canadians. more

We have moved!

Effective Sept 1/19 our new address is 100-1964 Park St. Regina, SK S4N 7M5. All phone/fax and email addresses remain the same.

Dr. M. Davis of Kamsack Resigned July 18, 2019

Dr. Murray Davis has resigned as a member of College of Physicians and Surgeons of Saskatchewan (CPSS) effective July 18, 2019. more

Prescribing Privileges for SK Podiatrists

Saskatchewan podiatrists recently received legislated authority to prescribe certain categories of medications. more

Dr. N. Maree prohibited from prescribing PRP

Dr. Narinda Maree will be practising under supervision and is prohibited from prescribing PRP medications more

Urgent Notice - Dr. Moolla Methadone Patients

Guidance for interim supply of methadone and buprenorphine/naloxone – Dr. H. Moolla more

Dr. Fern has Returned to Practice

As of May 23, 2019, Dr. Fern has returned to practice, resumed treating and prescribing Opioid Agonist Therapy for his patients more

Pharmacy Suspension Notice: Dewdney Drugs (1986) Ltd. – UPDATE

Resulting from the closure of Dewdney Drugs (1986) Ltd., it has become necessary for patients, NHIB clients, pharmacists more

Suspension - Dewdney Drugs (Regina)

Please be advised that SCPP has suspended the permit of Dewdney Drugs (1986) Ltd. until further notice as of 4:00 p.m. Thursday May 2, 2019, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1 more

Communication to Members - Dr. Paul and Dr. R. Patel Methadone Patients

Saskatchewan will be the first province in Canada to be provided with an exemption 56 to provide more


Please be advised that SCPP has suspended the license to practice pharmacy for member Arthur Woo (D1971) until further notice, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1 more

Changes to Mifegymiso Ultrasound no longer required

Health Canada is informing Canadians that the prescribing and patient information for Mifegymiso has been updated more

Health Canada Drug Recall

Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity

Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer. more

2019 Wellspring Leadership Award

The Canadian Foundation for Pharmacy is pleased to announce the 2019 Wellspring Pharmacy Leadership Award Program more

Regulatory Bylaw Certificate - Methadone

Approval of the Registrar of the College of Physicians and Surgeons (CPSS) is not required when prescribing methadone for pain. There are also other exemptions more


Please be advised that SCPP has temporarily suspended the license to practice pharmacy for member Jennifer Yaholnistky (D4587) pending investigation of professional misconduct, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1

Sask. Polytechnic SPTA Course

Saskatchewan Polytechnic is now accepting registrations for the Structured Practical Training and Assessment (SPTA) course Course listing


ella™ (ulipristal acetate) is an oral emergency contraceptive product. McKesson has identified a shortage until about December 7

New number to call for people seeking info about MAID

People seeking medically assisted death can now call the provincial 811 health line (CBC news)


On October 1, 2018, Health Canada provided a notice regarding opioid sticker and patient handout requirements. Please click here for recent updates to section 4.4 of the guidance document, outlining when an opioid would not require the sticker and handout.

Mandatory Opioid Warning Sticker and Patient Information Handout

Health Canada announced "Regulations Amending the Food and Drug Regulations" on opioids that will alter the current opioid dispensing workflow of pharmacists more

Zhejiang Huahai Pharmaceuticals site non-compliant

Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients. No products are being recalled at this time more

Influenza Immunization Program

The Saskatchewan Influenza Immunization Policy (SIIP) 2018-2019 is available in the Reference Manual or here. The DPEBB Influenza Immunization Program: Policy and Procedures is available here.


Find CE Online Courses and Live Events: www.usask.ca/cpdpp
Regulatory Updates


Subsection 56(1) Class Exemption expires on September 30, 2019. Exemption info MicroSCOPe article..


At the December meeting, Council decided not to extend the temporary bylaw that came into effect on August 27, 2018, which moved epinephrine ampoules from Schedule I to Schedule II for the treatment of anaphylaxis due to allergens. Therefore, effective December 31, 2018, epinephrine ampoules for anaphylaxis are no longer Schedule II and are back on Schedule I status...

Naloxone Unscheduled

Saskatchewan becomes the third province to move naloxone to unscheduled status more..


Effective March 16, 2018, Part N, section 11(2) of the SCPP Regulatory Bylaws was repealed (linked document updated March 22) more..


Please review the November 7, 2017, Health Canada updates to prescribing and dispensing information for Mifegymiso®  here ..


The Minister of Health has approved the bylaws that set the Continuous Quality Improvement (CQI) program requirement, which will be met by COMPASS starting with the 2017-2018 permit year. The new bylaws can be found in Section 12 of Part I in the SCPP Regulatory Bylaws.  more ..


Effective July 20, 2017, topical minoxidil, in concentrations of 5% or less, is now an unscheduled product and may be sold from any retail outlet (including online)  more ..

CSHP AGM, Education Sessions and Awards Banquet (Saskatoon)

October 18-19 in Saskatoon, CSHP Annual General Meeting, Education Sessions and Awards Banquet more   

CFP Pharmacy Forum

Nov 20 in Toronto. Hear from industry leaders as they explore CFP's vision for the future of pharmacy. more   

Calendar View


Powered by in1touch